Tumors With CDK4/6 Pathway Activation
1 clinical trials · Condition
◉ Watch Tumors With CDK4/6 Pathway Activation
| Record | Firm | Date |
|---|---|---|
| LEE011 for Patients With CDK4/6 Pathway Activated Tumors (SIGNATURE) (NCT02187783) | Novartis Pharmaceuticals | 2014-08-25 |
Track Tumors With CDK4/6 Pathway Activation automatically
Every clearance here is in the API, with alerts when new ones post.